, Volume 9, Issue 3, pp 625–636 | Cite as

Albendazole Electrospun Nanofiber Films: In-vitro and Ex-vivo Assessment

  • R. N. KambleEmail author
  • R. V. Mehtre
  • P. P. Mehta
  • P. Nangare
  • S. S. Patil


Albendazole (ABZ) is a broad-spectrum, synthetic benzimidazole anthelmintic approved by the US FDA in 1996. However, it exhibits low oral bioavailability owing to its high lipophilicity and poor water solubility. Moreover, if such a drug molecule is projected for the therapy of a particular group of the population, for example, pediatric or geriatric, the formulation challenge is even greater with the need to manufacture a dosage form that is suitable for particular patients. Hence, the aim of the present study was to investigate electrospun polyvinyl alcohol (PVA) nanofiber films as a new delivery system adopted for the oromucosal administration of ABZ. The prepared nanofiber films were evaluated regarding their mechanical and physicochemical properties, in vitro drug release, and ex vivo permeation. Scanning electron microscopy was used to prove the formation of uniform, non-woven, smooth nanofibers. ABZ-loaded PVA nanofiber films showed ~ 5-fold improvement in the dissolution rate of ABZ as compared to ABZ alone. Additionally, an ex vivo permeation study in a goat buccal mucosa displayed 3.2-fold improvement in the permeation of ABZ from PVA nanofiber films. The prepared nanofiber films were found to be stable over the period of 3 months, confirmed from accelerated stability studies. Accordingly, electrospinning was shown to be a capable nanotechnology-based strategy for the formulation of poorly water-soluble molecules so as to improve their primary and secondary biopharmaceutical properties. Thus, oromucosal administration of drug-loaded nanofiber films could be a promising approach for pediatric or geriatric patients.


Albendazole Polyvinyl alcohol Oromucosal delivery Electrospinning Nanofiber films Ex vivo permeation 



The authors would like to acknowledge the support from Bharati Vidyapeeth (Deemed to be) University, Poona College of Pharmacy, Pune, Maharashtra, India.

Funding Information

There are no funding agencies to report for this work.

Compliance with Ethical Standards

Ethical Statements

The present work does not involve any animal or human volunteer.

Conflict of Interest

The authors declare that they have no conflict of interest.

Research Involving Humans and Animals Statement


Informed consent



  1. 1.
    Kamble, R., Bothiraja, C., Mehta, P., & Varghese, V. (2017). Synthesis, solid state characterization and antifungal activity of ketoconazole cocrystals. Journal of Pharmaceutical Investigation.
  2. 2.
    Kamble, R., Sharma, S., & Mehta, P. (2017). Norfloxacin mixed solvency based solid dispersions: an in-vitro and in-vivo investigation. Journal of Taibah University for Science, 11, 512–522.CrossRefGoogle Scholar
  3. 3.
    Dhapte, V., & Mehta, P. (2015). Advances in hydrotropic solutions: an updated review. St. Petersburg Polytechnical University Journal: Physics and Mathematics, 1, 424–435.CrossRefGoogle Scholar
  4. 4.
    Kamble, R., Mehta, P., & Kumar, A. (2016). Efavirenz self-nano-emulsifying drug delivery system: in vitro and in vivo evaluation. AAPS PharmSciTech, 17, 1240–1247.CrossRefGoogle Scholar
  5. 5.
    Hearnden, V., Sankar, V., Hull, K., Juras, D., Greenberg, M., Kerr, A., Lockhart, P., Patton, L., Porter, S., & Thornhill, M. (2012). New developments and opportunities in oral mucosal drug delivery for local and systemic disease. Advanced Drug Delivery Reviews, 64, 16–28.CrossRefGoogle Scholar
  6. 6.
    Gegel, N., Abramov, A., Shipovskaya, A., & Zudina, I. (2016). A biocidal nanocoating based on the macromolecular chitosan acetate-sodium albuminate-silver nanoparticles system. BioNanoSci.
  7. 7.
    Parejiya, P., Patel, R., Mehta, D., Shelat, P., & Barot, B. (2013). Quick dissolving films of nebivolol hydrochloride: formulation and optimization by a simplex lattice design. Journal of Pharmaceutical Investigation, 43, 343–351.CrossRefGoogle Scholar
  8. 8.
    Vijayanand, P., Patil, J., & Reddy, M. (2015). Formulation and comparative pharmacokinetic evaluation of orodispersible tablets and films of nebivolol hydrochloride. Journal of Pharmaceutical Investigation, 45, 237–247.CrossRefGoogle Scholar
  9. 9.
    Colombo, P., Cagnani, S., Sonvico, P., & Santi, P. (2007). Biological in vitro models for absorption by non oral routes. Comprehensive Medicinal Chemistry II, 5, 279–299.CrossRefGoogle Scholar
  10. 10.
    Pawar, A., Rajalakshmi, S., Mehta, P., Shaikh, K., & Bothiraja, C. (2016). Strategies for formulation development of andrographolide. RSC Advances, 6, 69282–69300.CrossRefGoogle Scholar
  11. 11.
    Bhardwaj, N., & Kundu, S. (2010). Electrospinning: a fascinating fiber fabrication technique. Biotechnology Advances, 28, 325–347.CrossRefGoogle Scholar
  12. 12.
    Bakhtiari, M., Salehi, R., Akbarzadeh, A., & Davaran, S. (2017). Development of novel doxorubicin loaded biodegradable polymeric nanofibers as the anticancer drug delivery systems. BioNanoSci.
  13. 13.
    Reda, R., Wen, M., & El-Kamel, A. (2017). Ketoprofen-loaded Eudragit electrospun nanofibers for the treatment of oral mucositis. International Journal of Nanomedicine, 12, 2335–2351.CrossRefGoogle Scholar
  14. 14.
    Kamble, R., Gaikwad, S., Maske, A., & Patil, S. (2016). Fabrication of electrospun nanofibers of BCS II drug for enhanced dissolution and permeation across skin. Journal of Advanced Research, 7, 483–489.CrossRefGoogle Scholar
  15. 15.
    Bhandari, J., Mishra, H., Mishra, P., Wimmer, R., Ahmad, F., & Talegaonkar, S. (2017). Cellulose nanofiber aerogel as a promising biomaterial for customized oral drug delivery. International Journal of Nanomedicine, 12, 2021–2031.CrossRefGoogle Scholar
  16. 16.
    Kadajji, V., & Betageri, G. (2011). Water soluble polymers for pharmaceutical applications. Polymers, 3, 1972–2009.CrossRefGoogle Scholar
  17. 17.
    Dayan, A. (2003). Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Tropica, 86, 141–159.CrossRefGoogle Scholar
  18. 18.
    Mansuri, S., Kesharwani, P., Tekade, R., & Jain, N. (2016). Lyophilized mucoadhesive-dendrimer enclosed matrix tablet for extended oral delivery of albendazole. European Journal of Pharmaceutics and Biopharmaceutics, 102, 202–213.CrossRefGoogle Scholar
  19. 19.
    Ahmadnia, S., Moazeni, M., Mohammadi-Samani, S., & Oryan, A. (2013). In vivo evaluation of the efficacy of albendazole sulfoxide and albendazole sulfoxide loaded solid lipid nanoparticles against hydatid cyst. Experimental Parasitology, 135, 314–319.CrossRefGoogle Scholar
  20. 20.
    Casulli, A., Morales, M., Gallinella, B., Turchetto, L., & Pozio, E. (2006). 2-Hydroxypropyl-b-cyclodextrin improves the effectiveness of albendazole against encapsulated larvae of Trichinella spiralis in a murine model. The Journal of Antimicrobial Chemotherapy, 58, 886–890.CrossRefGoogle Scholar
  21. 21.
    Ibrahim, M., Shazly, G., & El-Badry, M. (2014). Albendazole microparticles prepared by spray drying technique: improvement of drug dissolution. Tropical Journal of Pharmaceutical Research, 13, 1963–1970.CrossRefGoogle Scholar
  22. 22.
    Meena, A., Sharma, K., Kandaswamy, M., Rajagopal, S., & Mullangi, R. (2012). Formulation development of an albendazole self-emulsifying drug delivery system (SEDDS) with enhanced systemic exposure. Acta Pharmaceutica, 62, 563–580.CrossRefGoogle Scholar
  23. 23.
    Shinde, R., Bharkad, G., & Devarajan, P. (2015). Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: role of docosahexaenoic acid. European Journal of Pharmaceutics and Biopharmaceutics, 96, 363–379.CrossRefGoogle Scholar
  24. 24.
    Kraisit, P., Limmatvapirat, S., Luangtana-Anan, M., & Sriamornsak, P. (2018). Buccal administration of mucoadhesive blend films saturated with propranolol loaded nanoparticles. Asian Journal of Pharmaceutical Science, 13, 34–43.CrossRefGoogle Scholar
  25. 25.
    Liew, K., Tan, Y., & Peh, K. (2011). Characterization of oral disintegrating film containing donepezil for alzheimer disease. AAPS PharmSciTech, 13, 134–142.CrossRefGoogle Scholar
  26. 26.
    Aydogdu, M., Oprea, A., Trusca, R., Surdu, A., Ficai, A., Holban, A., Iordache, F., Paduraru, A., Filip, D., Altun, E., Ekren, N., Oktar, F., & Gunduz, O. (2017). Production and characterization of antimicrobial electrospun nanofibers containing polyurethane, zirconium oxide and zeolite. BioNanoSci.
  27. 27.
    Goreninskii, S., Stankevich, K., Bolbasov, E., Danilenko, N., Filimonov, V., & Tverdokhlebov, S. (2017). Surface modification of PLLA electrospun nanofiber materials for biomedical applications. BioNanoSci.
  28. 28.
    Bothiraja, C., Shinde, M., Rajalakshmi, S., & Pawar, A. (2009). Evaluation of molecular pharmaceutical and in-vivo properties of spray-dried isolated andrographolide-PVP. The Journal of Pharmacy and Pharmacology, 61, 1465–1472.CrossRefGoogle Scholar
  29. 29.
    Hanif, M., & Zaman, M. (2017). Thiolation of arabinoxylan and its application in the fabrication of controlled release mucoadhesive oral films. Daru, 25, 1–13.CrossRefGoogle Scholar
  30. 30.
    Bothiraja, C., Pawar, A., Dama, G., Joshi, P., & Shaikh, K. (2012). Novel solvent free gelucire extract of Plumbago zeylanica using non-everted rat intestinal sac method for improved therapeutic efficacy of plumbagin. Journal of Pharmacology and Toxicology, 66, 35–42.Google Scholar
  31. 31.
    World Health Organization. (2009). Annex 2, WHO technical report series, no. 953, stability testing of active pharmaceutical ingredients and finished pharmaceutical products. Section 2.2.6, 101–103.Google Scholar
  32. 32.
    Poralan, G., Gambe, J., Alcantara, E., & Vequizo, R. (2015). X-ray diffraction and infrared spectroscopy analyses on the crystallinity of engineered biological hydroxyapatite for medical application. IOP Conference Series: Materials Science and Engineering, 79, 1–7.CrossRefGoogle Scholar
  33. 33.
    Kamble, R., Palve, P., & Mehta, P. (2014). Preparation and evaluation of amorphous olmesartan medoxomil with porous silica microparticles using spray-drying technique. Journal of Advanced Pharmacy Education and Research, 4, 65–71.Google Scholar
  34. 34.
    Mehta, P., & Dhapte, V. (2014). Propulsive PAT paradigm: optimization of freeze drying process. International Journal of Pharmaceutical Sciences Review and Research, 28, 240–246.Google Scholar
  35. 35.
    Potrc, T., Baumgartner, S., Roskar, R., Planinsek, O., Lavric, Z., Kristl, J., & Kocbek, P. (2015). Electrospun polycaprolactone nanofibers as a potential oromucosal delivery system for poorly water-soluble drugs. European Journal of Pharmaceutical Sciences, 75, 101–113.CrossRefGoogle Scholar
  36. 36.
    Vuddanda, P., Mathew, A., & Velaga, S. (2016). Electrospun nanofiber mats for ultrafast release of ondansetron. Reactive and Functional Polymers, 99, 65–72.CrossRefGoogle Scholar
  37. 37.
    Kwak, H., Woo, H., Kim, I., & Lee, K. (2017). Fish gelatin nanofibers prevent drug crystallization and enable ultrafast delivery. RSC Advances, 7, 40411–40417.CrossRefGoogle Scholar
  38. 38.
    Mehta, P., & Pawar, V. (2018). Electrospun nanofiber scaffolds: technology and applications. Applications of nanocomposite materials in drug delivery (pp. 509–573). Sawston: Woodhead Publishing Series in Biomaterials.CrossRefGoogle Scholar
  39. 39.
    Dott, C., Tyagi, C., Tomar, L., Choonara, Y., Kumar, P., du Toit, L., & Pillay, V. (2013). A mucoadhesive electrospun nanofibrous matrix for rapid oramucosal drug delivery. Journal of Nanomaterials, 2013, 1–19.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • R. N. Kamble
    • 1
    Email author
  • R. V. Mehtre
    • 1
  • P. P. Mehta
    • 2
  • P. Nangare
    • 1
  • S. S. Patil
    • 1
  1. 1.Department of Pharmaceutics, Poona College of PharmacyBharati Vidyapeeth (Deemed to be University)PuneIndia
  2. 2.Department of Quality Assurance, Poona College of PharmacyBharati Vidyapeeth (Deemed to be University)PuneIndia

Personalised recommendations